Alzheimeri tõve geneetikast ja patofüsioloogiast
2. Kantor D,Zieve D. 2010. Alzheimer's disease.
Kättesaadav: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001767
3. F00-F09 Orgaanilised-k.a. sümptomaatilised- psüühikahäired
Kättesaadav: http://www.kliinikum.ee/psyhhiaatriakliinik/lisad/ravi/RHK/F0.htm
4. Lahiri DK, Farlow MR, Sambamurti K, Greig NH, Giacobini E, Schneider LS. 2003. A
critical analysis of new molecular targets and strategies for drug developments in Alzheimer's
disease. Current Drug Targets 4, 97-112.
5. Terry AV, Buccafusco JJ. 2003. The cholinergic hypothesis of age and Alzheimer's disease-
related cognitive deficits: recent challenges and their implications for novel drug
development.The journal of pharmacology and experimental therapeutics 306 (3), 821-827.
6. Ainetvahetushäired Patoloogilise anatoomia ja kohtuarstiteaduse instituudi
loengumaterjal.
Kättesaadav:http://biomedicum.ut.ee/arpa/pa/arstiteadused/loengumaterjale/3.%20AINEVAH
ETUSHAIRED.pdf
7. Querfurth HW, LaFerla FM. 2010
annaabi.ee 
